OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN

This article describes an experience of treatment of children (n=92) with miction disorders - syndrome of hyperactive urinary bladder (HUB) with oxybutynin (Driptane). Treatment resulted in decrease of median grade of disorder of urination from 12.5 marks initially to 5.2 marks after 4 weeks of trea...

Full description

Saved in:
Bibliographic Details
Main Authors: L.B. Menovshchikova (Author), Z.Z. Sottayeva (Author)
Format: Book
Published: "Paediatrician" Publishers LLC, 2009-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article describes an experience of treatment of children (n=92) with miction disorders - syndrome of hyperactive urinary bladder (HUB) with oxybutynin (Driptane). Treatment resulted in decrease of median grade of disorder of urination from 12.5 marks initially to 5.2 marks after 4 weeks of treatment. This effect remained during 3 following months. Besides, the frequency of urinations was lessened in 23%, urgent feeling of urination - in 46%, urgent incontinence was stopped completely. Symptoms of enuresis were more resistant to treatment, and they were stopped completely in 6 children. Side effects, concerned with therapy, were registered in 3 (3%) children. Thus, oxybutynin in effective and safe medication for treatment of children with urinary disorders - HUB syndrome.Key words: children, syndrome of hyperactive urinary bladder, treatment, oxybutynin.(Voprosy sovremennoi pediatrii - Current Pediatrics. 2009;8(1):104-107)
Item Description:1682-5527
1682-5535